Alnylam Pharmaceuticals (ALNY) EBIT Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,386.07% |
| Dec 31, 2025 | 225.26% |
| Sep 30, 2025 | 578.49% |
| Jun 30, 2025 | -133.32% |
| Mar 31, 2025 | 141.62% |
| Dec 31, 2024 | 9.66% |
| Sep 30, 2024 | -135.96% |
| Jun 30, 2024 | 121.15% |
| Mar 31, 2024 | 71.01% |
| Dec 31, 2023 | 38.28% |
| Sep 30, 2023 | 182.88% |
| Jun 30, 2023 | -19.90% |
| Mar 31, 2023 | -2.10% |
| Dec 31, 2022 | 3.06% |
| Sep 30, 2022 | -42.03% |
| Jun 30, 2022 | -31.15% |
| Mar 31, 2022 | 21.22% |
| Dec 31, 2021 | -0.17% |
| Sep 30, 2021 | 19.33% |
| Jun 30, 2021 | 26.50% |
| Mar 31, 2021 | 11.37% |
| Dec 31, 2020 | 34.84% |
| Sep 30, 2020 | -4.11% |
| Jun 30, 2020 | 15.83% |
| Mar 31, 2020 | -11.32% |
| Dec 31, 2019 | -35.27% |
| Sep 30, 2019 | 15.03% |
| Jun 30, 2019 | -22.83% |
| Mar 31, 2019 | -28.07% |
| Dec 31, 2018 | -49.59% |
| Sep 30, 2018 | -102.35% |
| Jun 30, 2018 | -59.66% |
| Mar 31, 2018 | -38.39% |
| Dec 31, 2017 | -27.61% |
| Sep 30, 2017 | -17.93% |
| Jun 30, 2017 | -30.31% |
| Mar 31, 2017 | 3.20% |
| Dec 31, 2016 | -24.78% |
| Sep 30, 2016 | -36.19% |
| Jun 30, 2016 | -26.74% |
| Mar 31, 2016 | -110.69% |
| Dec 31, 2015 | -102.38% |
| Sep 30, 2015 | -73.30% |
| Jun 30, 2015 | -62.08% |
| Mar 31, 2015 | 80.59% |
| Dec 31, 2014 | -54.47% |
| Sep 30, 2014 | -40.22% |
| Jun 30, 2014 | -111.17% |
| Mar 31, 2014 | -2,644.43% |
| Dec 31, 2013 | 66.51% |
| Sep 30, 2013 | -77.63% |
| Jun 30, 2013 | -76.61% |
| Mar 31, 2013 | 10.00% |
| Dec 31, 2012 | -550.29% |
| Sep 30, 2012 | -45.90% |
| Jun 30, 2012 | 8.01% |
| Mar 31, 2012 | 30.51% |
| Dec 31, 2011 | -9.48% |
| Sep 30, 2011 | -42.51% |
| Jun 30, 2011 | -12.83% |
| Mar 31, 2011 | -38.65% |
| Dec 31, 2010 | -53.80% |
| Sep 30, 2010 | 9.55% |
| Jun 30, 2010 | 48.13% |